What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Disease
His primary scientific interests are in Internal medicine, Ulcerative colitis, Inflammatory bowel disease, Incidence and Epidemiology.
His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology and Surgery.
His Ulcerative colitis research is multidisciplinary, incorporating elements of Odds ratio, Colitis and Retrospective cohort study.
His Inflammatory bowel disease research includes elements of Oral mucosa, Irritable bowel syndrome, Biopsy and Immunology.
His Incidence research is multidisciplinary, relying on both Appendicitis, Pyogenic liver abscess, Population based study, Dysphagia and Inflammatory Bowel Diseases.
Gilaad G. Kaplan has researched Epidemiology in several fields, including Global health, Health care, Environmental health, Esophageal disease and Esophagogastroduodenoscopy.
His most cited work include:
- Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review (2933 citations)
- Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies (1327 citations)
- The global burden of IBD: from 2015 to 2025 (696 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Internal medicine, Inflammatory bowel disease, Crohn's disease, Ulcerative colitis and Gastroenterology.
His study explores the link between Internal medicine and topics such as Surgery that cross with problems in Cohort study.
Gilaad G. Kaplan interconnects Population based, Health care, Immunology and Intensive care medicine in the investigation of issues within Inflammatory bowel disease.
The concepts of his Ulcerative colitis study are interwoven with issues in Colitis and Infliximab.
His Gastroenterology research integrates issues from Vedolizumab and Primary sclerosing cholangitis.
As a part of the same scientific study, Gilaad G. Kaplan usually deals with the Incidence, concentrating on Epidemiology and frequently concerns with Environmental health.
He most often published in these fields:
- Internal medicine (50.63%)
- Inflammatory bowel disease (31.78%)
- Crohn's disease (23.16%)
What were the highlights of his more recent work (between 2018-2021)?
- Inflammatory bowel disease (31.78%)
- Internal medicine (50.63%)
- Disease (19.75%)
In recent papers he was focusing on the following fields of study:
Gilaad G. Kaplan focuses on Inflammatory bowel disease, Internal medicine, Disease, Crohn's disease and Ulcerative colitis.
His Inflammatory bowel disease research is multidisciplinary, incorporating perspectives in Epidemiology, Incidence, Health care, Intensive care medicine and Population based.
As part of his studies on Internal medicine, Gilaad G. Kaplan often connects relevant areas like Gastroenterology.
His Disease study integrates concerns from other disciplines, such as Psychological intervention, Quality of life, Pediatrics, Cohort and Comorbidity.
As a part of the same scientific family, he mostly works in the field of Crohn's disease, focusing on Infliximab and, on occasion, Adalimumab.
His study on Ulcerative colitis is mostly dedicated to connecting different topics, such as Bowel resection.
Between 2018 and 2021, his most popular works were:
- Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry. (211 citations)
- Past and Future Burden of Inflammatory Bowel Diseases Based on Modeling of Population-Based Data. (83 citations)
- Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases. (70 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Surgery
His primary areas of study are Inflammatory bowel disease, Disease, Crohn's disease, Internal medicine and Epidemiology.
His Inflammatory bowel disease research includes themes of Joinpoint regression, Health care, Combination therapy and Ulcerative colitis.
In his study, Erythema nodosum and Primary sclerosing cholangitis is inextricably linked to Comorbidity, which falls within the broad field of Ulcerative colitis.
The study incorporates disciplines such as Psychological intervention, Psychosocial, Quality of life, Distress and Cohort in addition to Disease.
His biological study spans a wide range of topics, including Gastroenterology and Ultrasound.
The various areas that Gilaad G. Kaplan examines in his Epidemiology study include Incidence, Young adult, Retrospective cohort study, Health policy and Risk factor.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
